Skip to main content

BREAST: CB-4-23 | ELEVATE

Trial ID
NCT05563220
Trial Sponsor
Stemline Therapeutics, Inc.

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer (ELEVATE)